Back To Schedule
Thursday, June 17 • 12:00pm - 1:00pm
#512 OD: Electronic Labeling: Where are we Now and What are the Next Steps in the World?

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Session
Level: Intermediate

The most updated eLabeling initiatives in the US, EU, Canada, and Japan, and the trends for eLabeling in emerging markets will be shared. The possibility of the convergence of the eLabeling initiatives will be discussed in the digital health.v

Learning Objectives

Describe the most updated electronic labeling initiatives in the US, EU, Canada, Japan, and emerging countries; Discuss the possibility of the convergence for electronic labeling across regions.


Rie Matsui, RPh


eLabeling Updates in Japan and Collaboration with Asia Countries
Shinobu Uzu, MSc

Electronic Product Information (ePI) in the EU: Progress and the Road Ahead
Elizabeth Scanlan, PhD, MSc

Behind the Scenes in Implementing eLabeling: COVID-19 Vaccine Label Development During a Global Pandemic
Christine Wood, PhD

avatar for Shinobu Uzu

Shinobu Uzu

Senior Executive Director, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Mr. Shinobu Uzu is senior Executive Director, PMDA since April 2020. As Chief Safety Officer, PMDA, he was responsible for post-market surveillance and GMP/QMS audit of pharmaceuticals, medical devices regulated by Pharmaceuticals and Medical Devices Law until March 2018. Mr. Uzu... Read More →
avatar for Rie Matsui

Rie Matsui

Senior Director, Regional Labeling Head for APAC, Pfizer R&D, Japan
Rie Matsui is Senior Director, Regional Labeling Head for APAC, International Labeling Group(ILG), Global Regulatory Affairs, Pfizer Japan. She is also the Head, External Engagements for ILG. She is the founder of Asia Labeling Hub at Pfizer that has created various local label updates... Read More →

Christine Wood

Global Labeling TA Director (Respiratory and Immunology), AstraZeneca, United Kingdom
Christine Wood has been with AstraZeneca for 24 years. Following a degree and PhD in Chemistry she joined AstraZeneca and has had multiple roles in the business including Medicinal Chemistry, Procurement, Global Regulatory Affairs and Operations Quality. She is now a Therapy Area... Read More →
avatar for Elizabeth Scanlan

Elizabeth Scanlan

Scientific Communication Officer, Stakeholders and Communication Division, European Medicines Agency, Netherlands
Elizabeth Scanlan joined the European Medicines Agency in 2016 where she is a Scientific Communication Officer, with a focus on communication of information on safe and effective use of medicines to patients and healthcare professionals. Prior to joining EMA, she worked in communication... Read More →

Thursday June 17, 2021 12:00pm - 1:00pm EDT
TBD Virtual Event Horsham, PA 19044
  09: Regulatory, Session |   01: ClinSafety-PV, Session |   20: Early Access Content, Session